U.S. Behavioral Health Market Size, Share, and Trends 2024 to 2034

Chapter 1    Introduction

1.1    Research Objective

1.2    Scope of the Study

Chapter 2    Research Methodology

2.1    Research Process

2.2    Market Research Process

2.3    Market Research Approach

2.4    Data Sources

2.5    Assumptions & Limitations

Chapter 3    Executive Summary

3.1    US behavioral health market snapshot

Chapter 4    Market Variables and Scope

4.1    Introduction of behavioral health

4.2    Classification and Scope

Chapter 5    COVID-19 Impact on US Behavioral Health Market

5.1    COVID-19 Landscape: US behavioral health industry impact

5.2    Mental disorder and substance disorder prevalence during COVID-19 pandemic

5.2.1    Young adults

5.2.2    Adults experiencing job loss or income insecurity

5.2.3    Parents and children

5.2.4    Communities of color

5.2.5    Essential workers

5.3    Policy responses

5.4    Behavioral health outlook

Chapter 6    US Behavioral Health Market Dynamics & Trends

6.1    US behavioral health market dynamics

6.1.1    Market drivers

6.1.1.1    Rise of digital behavioral health to drive the market

6.1.1.1.1    Trends in digital behavioral health marketspace

6.1.2    Market restraint

6.1.2.1    Lack of coverage and inadequate reimbursement to restrain the market growth

6.1.3    Market opportunity

6.1.3.1    Payer-based strategy to provide opportunities for market growth

6.2    Reimbursement & regulatory scenario

6.2.1    Laws and regulations

6.2.1.1    SUPPORT Act

6.2.1.2    21st Century Cures

6.2.1.3    Comprehensive Addiction and Recovery Act (CARA)

6.2.1.4    Affordable Care Act (ACA)

6.2.1.5    Tribal Law and Order Act (TLOA)

6.2.1.6    Mental Health Parity and Addiction Equity Act

6.2.1.7    Americans with Disabilities Act (ADA)

6.2.1.8    Sober Truth on Preventing (STOP) Underage Drinking Act

6.2.1.9    Garrett Lee Smith Memorial Act

6.2.1.10    Children’s Health Act

6.2.1.11    Charitable Choice

6.2.1.12    Emergency Response

6.2.1.13    Protection and Advocacy for Individuals with Mental Illness Program

6.2.1.14    Synar Amendment and Tobacco Regulation for Substance Abuse Prevention and Treatment Block Grants

6.2.1.15    Federal Workplace Drug Testing

6.2.1.16    Opioid Drug Treatment

6.2.1.17    Patient Record Confidentiality

6.2.1.18    Other Federal Regulations Related to SAMHSA

6.2.2    Coverage

6.2.3    Reimbursement

6.2.3.1    TRICARE Inpatient Mental Health Per Diem Payment System

6.2.3.2    PHP rates

6.3    Role of telehealth in behavioral health

6.3.1    Background

6.3.2    Benefits

6.3.2.1    Provider experience

6.3.2.2    Client experience

6.3.2.3    Population health

6.3.2.4    Costs

6.3.2.5    Health equity and telehealth

6.3.3    Implementation of telehealth

6.3.4    Barriers to telehealth

6.3.5    Future of telehealth

6.3.6    Example of telehealth implementation

6.3.6.1    Eastern Shore Mobile Care Collaborative (ESMCC)

6.3.6.1.1    Client population

6.3.6.1.2    Forms of telehealth

6.3.6.1.3    Services offered through telehealth modalities

6.3.6.1.4    Findings and outcome

6.3.6.1.5    Lessons learned

6.3.6.2    Citywide Case Management Program

6.3.6.2.1    Client population

6.3.6.2.2    Forms of telehealth

6.3.6.2.3    Services offered through telehealth modalities

6.3.6.2.4    Findings and outcome

6.3.6.2.5    Lessons learned

6.4    Porter’s five forces analysis

Chapter 7    US Behavioral Health Market, By Services

7.1    US behavioral health market, by service, 2023-2032

7.1.1    US behavioral health pre-COVID-19 market size and estimations, by service, 2021-2032

7.1.2    US behavioral health post-COVID-19 market size and estimations, by service, 2021-2032

7.2    Home-based treatment services

7.3    Outpatient counseling

7.4    Emergency mental health services

7.5    Inpatient hospital treatment

7.6    Intensive care management

Chapter 8    US Behavioral Health Market, By Disorder

8.1    US behavioral health market, by disorder, 2023-2032

8.1.1    US behavioral health pre-COVID-19 market size and estimations, by disorder, 2021-2032

8.1.2    US behavioral health post-COVID-19 market size and estimations, by disorder, 2021-2032

8.2    Bipolar disorder

8.3    Anxiety & depression disorder

8.4    Post-traumatic stress disorder (PTSD)

8.5    Eating disorder

8.6    Substance abuse disorder

8.7    Other disorders

Chapter 9    US Behavioral Health Market, By End-user

9.1    US behavioral health market, by end-user, 2023-2032

9.1.1    US behavioral health pre-COVID-19 market size and estimations, by end-user, 2021-2032

9.1.2    US behavioral health post-COVID-19 market size and estimations, by end-user, 2021-2032

9.2    Outpatient clinics

9.3    Hospitals

9.4    Rehabilitation centers

9.5    Homecare settings

Chapter 10    US Behavioral Health Market, By Payer

10.1    US behavioral health market, by payer, 2023-2032

10.1.1    US behavioral health pre-COVID-19 market size and estimations, by payer, 2021-2032

10.1.2    US behavioral health post-COVID-19 market size and estimations, by payer, 2021-2032

10.2    Medicare & Medicaid

10.3    Self-pay

10.4    Private insurance & others

Chapter 11    Competitive Landscape

11.1    Company market share/positioning analysis

11.2    Strategies adopted by key players

Chapter 12    Company Profiles

12.1    Acadia Healthcare

12.1.1    Company overview

12.1.2    Business outline

12.1.3    Services offered

12.1.4    Financial performance

12.1.5    Recent initiatives

12.2    Promises Behavioral Health (Elements Behavioral Health)

12.2.1    Company overview

12.2.2    Business outline

12.2.3    Services offered

12.2.4    Recent initiatives

12.3    Epic Health Services (Aveanna Healthcare)

12.3.1    Company overview

12.3.2    Business outline

12.3.3    Services offered

12.4    Universal Health Services

12.4.1    Company overview

12.4.2    Business outline

12.4.3    Product line

12.4.4    Financial performance

12.4.5    Recent initiatives

12.5    Behavioral Health Group, Inc.

12.5.1    Company overview

12.5.2    Business outline

12.5.3    Product line

12.5.4    Recent initiatives

12.6    IBH Population Health Solutions

12.6.1    Company overview

12.6.2    Business outline

12.6.3    Service offering

12.6.4    Recent initiatives

12.7    CuraLinc Healthcare

12.7.1    Company overview

12.7.2    Business outline

12.7.3    Service offering

12.8    North Range Behavioral Health

12.8.1    Company overview

12.8.2    Business outline

12.8.3    Services offered

12.8.4    Recent initiatives

12.9    Ardent Health Services

12.9.1    Company overview

12.9.2    Business outline

12.9.3    Services offered

12.9.4    Financial performance

12.9.5    Recent initiatives

12.10    CRC Health Group

12.10.1    Business outline

12.11    List of other companies

12.11.1    National mental health organizations

12.11.2    Behavioral health technology start-up companies